MGNX
$15.41
Revenue | $11Mn |
Net Profits | $-45.83Mn |
Net Profit Margins | -416.55% |
Macrogenics, Inc.’s revenue fell -84.54% since last year same period to $11Mn in the Q4 2023. On a quarterly growth basis, Macrogenics, Inc. has generated 5.83% jump in its revenue since last 3-months.
Macrogenics, Inc.’s net profit fell -458.01% since last year same period to $-45.83Mn in the Q4 2023. On a quarterly growth basis, Macrogenics, Inc. has generated -361.1% fall in its net profits since last 3-months.
Macrogenics, Inc.’s net profit margin fell -2415.92% since last year same period to -416.55% in the Q4 2023. On a quarterly growth basis, Macrogenics, Inc. has generated -346.72% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.64 |
EPS Estimate Current Year | -0.64 |
Macrogenics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.64 - a -326.67% fall from last quarter’s estimates.
Macrogenics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.64.
Earning Per Share (EPS) | -0.75 |
Macrogenics, Inc.’s earning per share (EPS) fell -457.14% since last year same period to -0.75 in the Q4 2023. This indicates that the Macrogenics, Inc. has generated -457.14% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-11-06 | -0.1 | 0.28 | 380% |
2023-05-09 | 0.45 | -0.61 | -235.56% |
2024-03-07 | -0.15 | -0.75 | -400% |
2023-08-09 | -0.52 | -0.69 | -32.69% |